Novartis News

David Gardner called it. Hea s up 1,334%! See what Davida s recommending that you buy NEXT.

Novartis has gained exclusive rights to two oral targeted investigational therapies for patients with a range of life-threatening blood disorders and cancers that currently do not have effective treatment options.

Incyte Corp., /quotes/comstock/15*!incy /quotes/nls/incy the Wilmington, Del., drug developer focused on cancer, inflammation and diabetes, said it licensed two investigational hematology-oncology therapies to Novartis, /quotes/comstock/13*!nvs /quotes/nls/nvs /quotes/comstock/06p!novn the Basel health-care giant.

The deal step taken by Gleevec-experienced Novartis AG - probably Incyte Corp.'s most logical big-pharma partner outside the U.S. for its Phase III JAK1/2 inhibitor against myelofibrosis - may not have surprised many, but adding another, earlier-stage compound in the cMET inhibitor class made a nice bonus.

Identifying the best investment opportunities in the sector takes time. So we've built this "Prospecting" screen -- which is a simplified version of the special checklist that has helped Jeff Fischer and the Motley Fool Pro team -- to accelerate your research and help you identify companies that may make a winning addition to your portfolio.

Deerfield-based Baxter International Inc. says it is looking into building a cell-based vaccine manufacturing plant in the U.S. to produce seasonal and pandemic flu vaccines.

'Tis the season for pharmaceutical deals as drug-makers try to pad their pipeline with promising compounds.

Idera Pharmaceuticals Inc. on Wednesday announced the end of a research partnership with Novartis AG, but said Merck & Co.

Swiss pharmaceutical giant Novartis gave U.S. efforts to combat pandemic influenzas a boost with the Nov.

Herea s how India will become the place for future investment and future pharmacological breakthroughs.

BASEL, Switzerland - Swiss pharmaceuticals maker Novartis AG has opened the first U.S. plant to produce flu vaccines using cell cultures instead of egg-based methods, it said Tuesday.

Here's what Jim Cramer had to say about some of the stocks that callers offered up during the "Mad Money Lightning Round" Monday evening.

From M2 Europharma 20 November 2009 - Swiss drug maker Novartis AG said Friday it will raise the payments of its employees in Basel and in the plants in the Rheine valley by an average of 1.5% as of April 2010.

The opening ceremony for the first large-scale US Flu Cell Culture and adjuvant manufacturing facility, developed in partnership with the U.S. Department of Health and Human Services, will be held Tues.

Marvelle Sullivan, the head of corporate legal M&A at Novartis AG , spoke at The Deal Economy 2010 conference on Wednesday in New York City.

Protein Sciences Corp. may win backing from a U.S. panel today for a flu vaccine that can be produced in a third of the time it takes Sanofi-Aventis SA , GlaxoSmithKline Plc and Novartis AG to make their shots.

Pfizer Inc. plans to release generic drugs in Japan as early as 2011, expecting demand to increase as industrialized nations intensify efforts to control drug prices, according to a report Thursday.

A fair amount of uncertainty continues to surround the healthcare sector as Congress debates how it can improve the existing system in the U.S. , but that has not prevented a number of stocks in the space from storming up the charts.

Healthcare solutions provider Novartis declared on Thursday the launch of Prevacid24HR over-the-counter in pharmacies and retail stores across the US to treat frequent heartburn.

Swiss drugmaker Novartis AG said Thursday it is on track to meet its U.S. government order for swine flu vaccine, seeking to calm fears in recent weeks that shipments and vaccination programs may be delayed.